On January 1 this year we offered a short list of just three “major” trials that we were hoping to see results from in 2011. One of these trials was the randomized, U.S.-based trial of “palliative expectant management” vs. radical surgery in men with localized prostate cancer (the Prostate Cancer Intervention Versus Observation Trial or PIVOT).
As we have indicated previously, there have been problems with the structure of and the enrollment of patients into this trial since Day 1.
At 10:10 am next Tuesday, at the annual meeting of the American Urological Association (AUA) in Washington, DC, we will be able to get the scoop on whether this trial offers us data that is substantially different to the Scandinavian trial of watchful waiting vs. radical prostatectomy that offered 15-year follow-up data just a week ago.
Since this is a “late-breaking” paper, there is no abstract available at this time to give us any insight into what Dr. Wilt will be presenting. However, we suspect that reactions to whatever data get presented are likely to be “colored” by the views of the commentators on the structure and conduct of the actual trial.
Filed under: Management, Treatment Tagged: | expectant management, PIVOT, radical prostatectomy
Search for new and
ongoing trials on the
CTAG PCa web site
